Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
OBiO Technology Congratulates on The First Clinical Gene Editing Therapy to Treat An Overseas Patient in China by CorrectSequence Therapeutics 2024-08-06 11:01
OBiO Technology Officially Launched the Center for Clinical Evaluation and Translation of Advanced Therapies for Pediatric Rare and Genetic Diseases 2024-05-30 21:00
OBiO Technology will showcase at American Society of Gene & Cell Therapy 2024-04-29 00:00
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product 2023-10-24 12:05
OBiO and CHINAGENE reached a strategic agreement of commercial manufacturing services for gene therapy products 2023-04-29 23:20
A new super factory with 29 GMP grade production lines for gene and cell therapy was launched in Shanghai by OBiO technology 2023-04-24 22:36
FDA Accepts GMP Plasmid DMF of OBiO Technology 2023-01-17 08:00
OBiO Technology to Present Data on OVersatile™ Platform for Process Development of Herpes Simplex Virus and Vaccinia Virus Products at the 25th ASGCT Annual Meeting 2022-05-09 19:40
OBiO Technology Goes Public on Shanghai Stock Exchange Today 2022-03-22 13:00
1